Skip to main content

Russell Investments Group, Ltd.

Position in KROS — Keros Therapeutics, Inc.

CIK 1692234 Seattle, WA

Position in KROS

as of Jun 30, 2026 · filed Aug 6, 2026
Position Value
$651,539
-$246,130 QoQ
Shares Held
60,892
-25.1% QoQ
Ownership
0.307%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#47
of 131 holders
Holding Since
Sep 2022
16 quarters on record
Voting authority Sole 94% Shared 0% None 6%

Common Shares in KROS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Russell Investments Group, Ltd. holds $1,494,413,888 across 308 Biotechnology names. KROS ranks #138 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in KROS

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $651,539 60,892
2026-03-31 $897,669 81,311
2025-12-31 $1,644,555 80,774
2025-09-30 $1,471,874 93,039
2025-06-30 $824,267 61,743
2025-03-31 $84,108 8,254
2024-12-31 $527,471 33,321
2024-09-30 $5,941,489 102,316
2024-06-30 $3,763,484 82,352
2024-03-31 $5,451,701 82,352
2023-12-31 $3,759,584 94,557
2023-09-30 $2,418,894 75,875
2023-06-30 $2,754,819 68,562
2023-03-31 $2,373,521 55,586
2022-12-31 $1,978,758 41,207
2022-09-30 $935,194 24,859